Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

about

Endoscopic sphenopalatine artery ligation for acute idiopathic epistaxis. Do anatomical variation and a limited evidence base raise questions regarding its place in management?A medley of flavours.Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia

P2860

Q39126840-F3D167B4-3D31-4AD2-B910-1C68C3138B11 Q47689609-1CD9BDFC-39F3-4059-99D0-7960F39CF025 Q58125263-0CB60AB8-49DD-4CC6-8F99-DF9FB9D64953

P2860

Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

Item

http://www.wikidata.org/entity/Q38367321

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

@en

type

Item

label

Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

@en

prefLabel

Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

@en

P1476

Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

@en

P2093

I Syed

http://www.w3.org/2001/XMLSchema#string

V S Sunkaraneni

http://www.w3.org/2001/XMLSchema#string

P2860

Office-based pulsed dye laser treatment for hemorrhagic telangiectasias and epistaxis.

Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia.

Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.

Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.

The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.

The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.

A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia.

Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.

P304

410-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0022215115000365

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25736077

http://www.w3.org/2001/XMLSchema#string

P921

nosebleed

Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

about

P2860

P2860

Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921